Mani Mohindru

Mani Mohindru

DirectoratCytomX Therapeutics· In proxies 2023–2025

Mani Mohindru sits on 8 public boards.

Boards2

  • CytomX TherapeuticsDirector · 5 yr on the boardIndependentAudit—Paid as an executive
  • Cardiff OncologyDirector · 3 yr on the boardIndependentAudit, Nominating—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. CytomX TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +63%
  2. Cardiff OncologyPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. CytomXPublic company
    • Director? – PresentNo stock prices for these years
  4. Roshon TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  5. SAB Biotherapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. NovasentaPublic company · 3 yr
    • Director2021 – 2024 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?